beta2-microglobulin/B7 fusion proteins (NCI)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebeta2-microglobulin/B7 fusion proteins (NCI)
Drug Alias Namebeta2-microglobulin/B7 costimulator (NCI)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionBeta-2-microglobulin modulatorsCluster of differentiation 80 stimulants
TargetsBeta-2-microglobulinCluster of differentiation 80
Therapy Area/IndicationsNeoplasmsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsNeoplasmsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A